3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2/3
1
Status
Recruiting
2
Sponsor Class
OTHER
32
INDUSTRY
4
OTHER_GOV
2
NETWORK
2
NIH
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Conditions
Breast Neoplasms
18
Prostatic Neoplasms
15
Neoplasms
12
Multiple Myeloma
11
Carcinoma, Non-Small-Cell Lung
11
Melanoma
9
Pancreatic Neoplasms
6
Lymphoma, Non-Hodgkin
6
Lymphoma, Large B-Cell, Diffuse
6
Lymphoma
6
Colorectal Neoplasms
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Lung Neoplasms
5
Leukemia, Myeloid, Acute
5
Hodgkin Disease
5
Sarcoma
4
Ovarian Neoplasms
4
Osteosarcoma
4
Hematologic Neoplasms
4
Brain Neoplasms
4
Teratoma
3
Smoldering Multiple Myeloma
3
Small Cell Lung Carcinoma
3
Recurrence
3
Neoplasms, Germ Cell and Embryonal
3
Neoplasm Metastasis
3
Malignant Solid Neoplasm
3
HIV Infections
3
Fallopian Tube Neoplasms
3
Colonic Neoplasms
3
Interventions
Standard of Care
1
Specimen Handling
1
Practice Guidelines as Topic
1
Magnetic Resonance Spectroscopy
1
Letrozole
1
Laparoscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
NETWORK
×
Peritoneal Neoplasms
×
Clear all
NCT07001748
2026-05-15
STOPGAP II
Eastern Cooperative Oncology Group
Phase 2/3
Recruiting
148 enrolled
NCT04111978
2025-09-29
MATAO
Swiss GO Trial Group
Phase 3
Recruiting
540 enrolled